AMETEK (AME) is back in focus after a 10% increase in its quarterly dividend to $0.34 per share, paired with recent earnings that reported higher sales and net income for 2025.

Against that backdrop, AMETEK’s share price has climbed 6.54% over the past month and 20.99% over the past quarter, while its 1 year total shareholder return of 26.03% and 5 year total shareholder return of 97.57% indicate momentum that has been building rather than fading around the recent earnings, guidance and dividend news.

If this kind of steady story appeals to you, it could be worth broadening your search to other industrial names through our 23 top founder-led companies, which highlights businesses where leadership and long term execution are in focus.

With earnings, guidance and dividends all moving in the same direction, the question now is whether AMETEK at about $229 already reflects that strength or if the current valuation still leaves room for a buying opportunity.

Most Popular Narrative: 7.4% Undervalued

With AMETEK’s fair value from the most followed narrative at $248 against a last close of $229.76, the stock sits below that implied level, setting up a valuation story that leans on growth, margins and future earnings power rather than short term trading moves.

Adoption of digital reality, automation, and advanced metrology solutions is accelerating across key end markets such as aerospace, defense, and architecture, recently reinforced by the FARO Technologies acquisition, which has expanded AMETEK's addressable market and supported both revenue and margin growth through higher value, software-enabled recurring revenue streams.

Want to see what earnings path and profit profile sit behind that valuation gap? The narrative leans on steady top line progress, rising margins and a richer P/E assumption tied to those future cash flows. The full set of projections is where the story really gets interesting.

Result: Fair Value of $248 (UNDERVALUED)

However, there are still pressure points to watch, particularly any prolonged softness in semiconductor and research demand, or bumps in integrating acquisitions that could unsettle the earnings story.

Another View: Our DCF Flags AMETEK as Expensive

While the narrative fair value of $248 suggests AMETEK is 7.4% undervalued, our DCF model points the other way. Based on future cash flows, AMETEK at $229.76 sits above an estimated value of $167.87, which frames the shares as expensive rather than cheap. Which perspective do you think best fits the risk you are willing to take?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out AMETEK for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 54 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own AMETEK Narrative

If you are not on board with these views or simply prefer to stress test the numbers yourself, you can create your own full narrative in just a few minutes and Do it your way.

A great starting point for your AMETEK research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.

Looking for more investment ideas?

If AMETEK has you thinking more broadly about your portfolio, it makes sense to line up a few other candidates that fit different roles for your goals.

• Target resilient balance sheets by scanning a solid balance sheet and fundamentals stocks screener (44 results), which focuses on companies with fundamentals that may better handle bumps in the market.
• Hunt for value by checking out our 54 high quality undervalued stocks, where you can see which stocks currently trade below their assessed worth.
• Strengthen your income stream with a 13 dividend fortresses, which highlights companies offering higher yields alongside an emphasis on payout stability.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.